Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Radiolabeled Peptides in Imaging and Therapy: Basic and Clinical Perspectives

Author(s): Seyed Jalal Hosseinimehr

Volume 27, Issue 41, 2020

Page: [6966 - 6967] Pages: 2

DOI: 10.2174/092986732741201103122538

« Previous Next »
[1]
Cao, R.; Liu, H.; Cheng, Z. Radiolabeled peptide probes for liver cancer imaging. Curr. Med. Chem., 2020, 27(41), 6968-6986.
[http://dx.doi.org/10.2174/0929867327666200320153837 ] [PMID: 32196443]
[2]
Fu, H.; Du, B.; Chen, Z.; Li, Y. Radiolabeled peptides for SPECT and PET imaging in the detection of breast cancer: preclinical and clinical perspectives. Curr. Med. Chem., 2020, 27(41), 6987-7002.
[http://dx.doi.org/10.2174/0929867327666200128110827] [PMID: 32003658]
[3]
Li, M.; Sagastume, E.A.; Lee, D.; McAlister, D.; DeGraffenreid, A.J.; Olewine, K.R.; Graves, S.; Copping, R.; Mirzadeh, S.; Zim-merman, B.E.; Larsen, R.H.; Johnson, F.L.; Schultz, M.K. 203/212Pb theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer. Curr. Med. Chem., 2020, 27(41), 7003-7031.
[http://dx.doi.org/10.2174/0929867327999200727190423] [PMID: 32720598]
[4]
Ferro-Flores, G.; Ocampo-Garcia, B.; Luna-Gutiérrez, M.; Santos-Cuevas, C.; Jimenez-Mancilla, N.; Azorin-Vega, E.; Melendez-Alafort, L. Radiolabeled protein-inhibitor peptides with rapid clinical translation towards imaging and therapy. Curr. Med. Chem., 2020, 27(41), 7032-7047.
[http://dx.doi.org/10.2174/0929867327666191223121211 ] [PMID: 31870259]
[5]
Kleynhans, J.; Kruger, H.G.; Cloete, T.; Zeevaart, J.R.; Ebenhan, T. In silico modelling in the development of novel radiolabelled peptide probes. Curr. Med. Chem., 2020, 27(41), 7048-7063.
[http://dx.doi.org/10.2174/0929867327666200504082256] [PMID: 32364063]
[6]
Mosayebnia, M.; Hajiramezanali, M.; Shahhosseini, S. Radiolabeled peptides for molecular imaging of apoptosis. Curr. Med. Chem., 2020, 27(41), 7064-7089.
[http://dx.doi.org/10.2174/0929867327666200612152655] [PMID: 32532184]
[7]
Mitran, B.; Tolmachev, V.; Orlova, A. Radiolabeled GRPR antagonists for imaging of disseminated prostate cancer - influence of labeling chemistry on targeting properties. Curr. Med. Chem., 2020, 27(41), 7090-7111.
[http://dx.doi.org/10.2174/0929867327666200312114902] [PMID: 32164503]
[8]
Tolmachev, V.; Stone-Elander, S.; Orlova, A. Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls. Lancet Oncol, 2010, 11(10), 992-1000.
[http://dx.doi.org/10.1016/S1470-2045(10)70088-7] [PMID: 20667780]
[9]
Khodadust, F.; Ahmadpour, S.; Aligholikhamseh, N.; Abedi, S.M.; Hosseinimehr, S.J. An improved (99m)Tc-HYNIC-(Ser)3-LTVSPWY peptide with EDDA/tricine as co-ligands for targeting and imaging of HER2 overexpression tumor. Eur. J. Med. Chem., 2018, 144, 767-773.
[http://dx.doi.org/10.1016/j.ejmech.2017.12.037] [PMID: 29291444]
[10]
Klingler, M.; Hormann, A.A.; Guggenberg, E.V. Cholecystokinin-2 receptor targeting with radiolabeled peptides: current status and future directions. Curr. Med. Chem., 2020, 27(41), 7112-7132.
[http://dx.doi.org/10.2174/0929867327666200625143035] [PMID: 32586246]
[11]
Gharibkandi, N.A.; Conlon, J.M.; Hosseinimehr, S.J. Strategies for improving stability and pharmacokinetic characteristics of radio-labeled peptides for imaging and therapy. Peptides, 2020, 133170385
[http://dx.doi.org/10.1016/j.peptides.2020.170385 ] [PMID: 32822772]
[12]
Hosseinimehr, S.J.; Tolmachev, V.; Orlova, A. Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design. Drug Discov. Today, 2012, 17(21-22), 1224-1232.
[http://dx.doi.org/10.1016/j.drudis.2012.07.002] [PMID: 22781499]

Rights & Permissions Print Cite
Article Metrics
15
© 2024 Bentham Science Publishers | Privacy Policy